Advertisement

Topics

Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks

06:44 EDT 29 Aug 2017 | Labiotech.eu

European CAR-T stocks have jumped following Gilead’s announcement that it will acquire Kite Pharma, Novartis’ main competitor to launch the first therapy. Yesterday, Gilead bought a $11.9Bn (€9.9Bn) ticket to enter the final leg of the race to launch the first ...

This awesome article Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks

NEXT ARTICLE

More From BioPortfolio on "Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...